Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Histochem Cell Biol ; 126(3): 335-42, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16521002

ABSTRACT

Tissue inhibitors of matrix metalloproteinases (TIMPs) comprise a family of four members, of which TIMP4 is characterized by being primarily restricted to cardiovascular structures. We demonstrate with immunohistochemical analysis of healthy human tissue that TIMP4 is present in medial smooth muscle cells and adventitial capillaries of arteries as well as in cardiomyocytes. Animal studies have suggested a role for TIMP4 in several inflammatory diseases and cardiovascular pathologies. We therefore examined whether TIMP4 is involved in human inflammatory cardiovascular disorders, specifically atherosclerosis, giant cell arteritis and chronic rejection of heart allografts. TIMP4 was most clearly visible in cardiovascular tissue areas populated by abundant inflammatory cells, mainly macrophages and CD3+ T cells. Using western blotting and immunocytochemistry, human blood derived lymphocytes, monocytes/macrophages and mast cells were shown to produce TIMP4. In advanced atherosclerotic lesions, TIMP4 was detected around necrotic lipid cores, whereas TIMP3 and caspase 3 resided within and around the core regions, indicating different roles for TIMP3 and TIMP4 in inflammation-induced apoptosis and in matrix turnover. In conclusion, the data demonstrate upregulation of TIMP4 in human cardiovascular disorders exhibiting inflammation, suggesting its future use as a novel systemic marker for vascular inflammation.


Subject(s)
Cardiovascular Diseases/etiology , Coronary Vessels/metabolism , Inflammation/etiology , Tissue Inhibitor of Metalloproteinases/immunology , Atherosclerosis/etiology , Atherosclerosis/immunology , Cardiovascular Diseases/immunology , Coronary Vessels/pathology , Giant Cell Arteritis/etiology , Giant Cell Arteritis/immunology , Graft Rejection/etiology , Graft Rejection/metabolism , Heart Transplantation , Humans , Macrophages/metabolism , Tissue Inhibitor of Metalloproteinase-3/metabolism , Tissue Inhibitor of Metalloproteinases/biosynthesis , Tissue Inhibitor of Metalloproteinases/blood , Tissue Inhibitor of Metalloproteinase-4
2.
J Ethnopharmacol ; 81(3): 327-36, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12127233

ABSTRACT

A 70% methanol extract of Terminalia chebula fruit, was studied for its effects on growth in several malignant cell lines including a human (MCF-7) and mouse (S115) breast cancer cell line, a human osteosarcoma cell line (HOS-1), a human prostate cancer cell line (PC-3) and a non-tumorigenic, immortalized human prostate cell line (PNT1A) using assays for proliferation ([(3)H]-thymidine incorporation and coulter counting), cell viability (ATP determination) and cell death (flow cytometry and Hoechst DNA staining). In all cell lines studied, the extract decreased cell viability, inhibited cell proliferation, and induced cell death in a dose dependent manner. Flow cytometry and other analyses showed that some apoptosis was induced by the extract at lower concentrations, but at higher concentrations, necrosis was the major mechanism of cell death. ATP assay guided chromatographic fractionation of the extract yielded ellagic acid, 2,4-chebulyl-beta-D-glucopyranose (a new natural product), and chebulinic acid which were tested by ATP assay on HOS-1 cell line in comparison to three known antigrowth phenolics of Terminalia, gallic acid, ethyl gallate, luteolin, and tannic acid. Chebulinic acid (IC(50) = 53.2 microM +/- 0.16) > tannic acid (IC(50) = 59.0 microg/ml +/- 0.19) > and ellagic acid (IC(50) = 78.5 microM +/- 0.24), were the most growth inhibitory phenolics of T. chebula fruit in our study.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Fruit/chemistry , Neoplasms/pathology , Phenols/pharmacology , Plant Extracts/pharmacology , Terminalia/chemistry , Adenosine Triphosphate/metabolism , Animals , Antineoplastic Agents, Phytogenic/chemistry , Apoptosis/drug effects , Breast Neoplasms/pathology , Cell Division/drug effects , Female , Humans , Inhibitory Concentration 50 , Male , Mammary Neoplasms, Animal/pathology , Mice , Molecular Structure , Necrosis , Osteosarcoma/pathology , Phenols/chemistry , Phytotherapy , Plant Extracts/chemistry , Prostatic Neoplasms/pathology , Time Factors , Tumor Cells, Cultured
3.
Vet Res ; 33(3): 271-81, 2002.
Article in English | MEDLINE | ID: mdl-12056478

ABSTRACT

Impaired polymorphonuclear neutrophil leukocyte (PMN) function around parturition has been associated with increased clinical mastitis in dairy cows. Rolling and attachment of PMN to the endothelium is the first step in the recruitment process and is accomplished by interaction between L-selectin on PMN and its ligand on endothelial cells. Furthermore, tyrosine phosphorylation is involved in the initiation of many PMN functions. The objective of this work was to determine changes in expression of L-selectin and tyrosine phosphorylation in the perinatal period. Eight clinically healthy Holstein cows were used as PMN donors at d-21, -14, -7,0 (calving), +1, +2, +7, +14, +28. Evaluation of L-selectin expression was carried out on activated and resting PMN. Anti-bovine L-selectin monoclonal antibody (MAB) and flow cytometric analysis were used to measure the percentage of PMN fluorescing and receptor expression (log mean fluorescent channel, LMFC). Activated and resting PMN showed similar trends in % PMN fluorescence and LM FC. The percentage of PMN fluorescing tended to decrease at parturition, followed by a significant increase at d +14 and +28 (P < 0.02). For LMFC a decrease was observed on d +1 followed by an increase through d +28 (P < 0.01). Protein tyrosine phosphorylation of lysates prepared from PMN isolated throughout the study was detected by electrophoresis and western blotting using anti-phosphotyrosine MAB. Several protein bands were tyrosine phosphorylated. Two of these bands (42-44 kDa and 90 kDa) varied in intensity over time. The intensity of the 42-44 kDa band gradually increased from d -7, peaked at d +7 (P < 0.03), and steadily decreased to d +28 (P < 0.02). Antibody to activated mitogen protein kinase reacted with the 42-44 kDa band. Reduced PMN function during the periparturient period could be related to reduced L-selectin adhesion molecules on the cell surface, and to modulation in the phosphorylation of functionally important molecules.


Subject(s)
Cattle/immunology , L-Selectin/physiology , Labor, Obstetric/immunology , Neutrophils/physiology , Tyrosine/metabolism , Animals , Antibodies, Monoclonal/blood , Antibodies, Monoclonal/immunology , Cattle/blood , Female , Flow Cytometry/veterinary , Fluorescence , Immunoblotting/veterinary , L-Selectin/immunology , Labor, Obstetric/blood , Mastitis, Bovine/etiology , Mastitis, Bovine/immunology , Phosphorylation , Pregnancy , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...